Skip to content
naulon
Not checkedNot checked for notices yet.

Incidence of benign lesions according to tumor size in solid renal masses

Victor Srougi, Raphael B. Kato, Fernanda A. Salvatore and 3 more

International Brazilian Journal of Urology · 2009

doi:10.1590/s1677-55382009000400005 (opens in a new tab)

We email you when a new notice or a question about this paper appears.

Abstract

OBJECTIVE: The incidence of solid renal masses has increased sharply in recent years due to widespread use of abdominal imaging studies. The aim of the present study was to evaluate the incidence of benign lesions in solid renal masses according to tumor size. MATERIALS AND METHODS: The authors retrospectively reviewed the records of 305 patients with 328 renal solid masses treated by surgery. Based on a report by one pathologist, the specimen tumor size and the histology of each lesion were tabulated. The frequency of renal cell carcinoma and benign renal lesions was evaluated and a correlation between tumor size and pathological features of the masses was observed. RESULTS: The frequency of malignant lesions in the 328 renal masses was 83.2%. When lesions were stratified into groups with diameters <or= 3 cm or > 3 cm, the incidence of benign histology was 22.9% and 13.3%, respectively (p = 0.026). The odds ratios for finding a benign lesion in masses <or= 3 cm was 1.93 (IC 95%, 1.07 - 3.46) compared to masses > 3 cm. CONCLUSION: The incidence of benign lesions is significantly higher in renal masses smaller than 3 cm in diameter, which should be taken in account when the treatment of renal solid masses is planned.

Abstract licence: CC BY

References20

    20 more references, whose wording the paper’s licence keeps private.

    Reads

    Read by people on this page

    None yet.

    Checked or read by AI through naulon

    None yet.

    A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

    Are you an author?

    Is this your paper?

    Claim it to add your note and be paid when agents cite it. Free.